BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Lung cancer
,
Retina
,
Human chorionic gonadotropin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Birc5;jsessionid=958527EC5C13A9A6822472F5A2488371;jsessionid=7264AC46B125F06A6A89AE1E442618B1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Conjunctiva
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Contribution of survivin to the immune system, allergies and autoimmune diseases.
Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel The…
Survivin is essential for thermogenic program and metabolic homeostasis in mice.
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker.
Silencing Survivin: a Key Therapeutic Strategy for Cardiac Hypertrophy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for Birc5;jsessionid=958527EC5C13A9A6822472F5A2488371;jsessionid=7264AC46B125F06A6A89AE1E442618B1
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ